GSK PLC-SPON ADR (GSK) Stock Earnings & Estimates
USA - New York Stock Exchange - NYSE:GSK - US37733W2044 - ADR
48.135 USD
+0.48 (+1.02%)
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 29.324B 18.74% | 30.328B 3.42% | 31.376B 3.46% | 33.479B 6.70% | 35.188B 5.10% | 36.803B 4.59% | 38.046B 3.38% | 38.984B 2.47% | 38.772B -0.54% | 38.593B -0.46% | 37.668B -2.40% | 37.825B 0.42% | |
| EBITDA YoY % growth | 10.542B 29.73% | 10.598B 0.53% | 10.688B 0.85% | 11.152B 4.34% | 11.969B 7.33% | 12.552B 4.87% | 13.56B 8.03% | 13.647B 0.64% | 13.533B -0.84% | 12.265B -9.37% | 10.927B -10.91% | 10.519B -3.73% | |
| EBIT YoY % growth | 8.395B 46.03% | 8.304B -1.08% | 8.137B -2.01% | 9.19B 12.94% | 9.996B 8.77% | 10.784B 7.88% | 12.592B 16.77% | 12.578B -0.11% | 12.197B -3.03% | 11.259B -7.69% | 10.733B -4.67% | 10.069B -6.19% | |
| Operating Margin | 28.63% | 27.38% | 25.93% | 27.45% | 28.41% | 29.30% | 33.10% | 32.26% | 31.46% | 29.17% | 28.49% | 26.62% | |
| EPS YoY % growth | 3.00 4.54% | 3.15 4.85% | 3.24 2.77% | 3.48 7.61% | 3.81 9.25% | 4.10 7.85% | 4.63 12.86% | 4.59 -0.84% | 4.53 -1.44% | 4.17 -7.95% | 3.48 -16.43% | 2.98 -14.58% |
All data in GBP
| Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|
| EPS Q2Q % growth | 0.48 2.54% | 0.97 6.82% | 1.04 9.76% | 1.18 5.71% | 0.48 -1.28% |
| Revenue Q2Q % growth | 8.699B 7.17% | 8.022B 6.73% | 8.586B 7.51% | 9.234B 8.04% | 8.698B -0.01% |
| EBITDA Q2Q % growth | 1.803B -53.14% | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | 1.536B 72.78% | 2.669B 15.34% | 2.815B 15.51% | 3.141B 12.70% | 1.84B 19.79% |
All data in GBP
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2025 Q2Q % growth | 1.12 10.66% | 0.99 | 0.13 | 12.80% |
| Q2 2025 Q2Q % growth | 0.94 7.14% | 0.88 | 0.07 | 7.67% |
| Q1 2025 Q2Q % growth | 0.91 4.18% | 0.83 | 0.08 | 9.85% |
| Q4 2024 Q2Q % growth | 0.47 -19.72% | 0.40 | 0.07 | 18.46% |
| Q3 2024 Q2Q % growth | 1.01 -1.39% | 0.91 | 0.10 | 10.89% |
| Q2 2024 Q2Q % growth | 0.88 11.86% | 0.79 | 0.09 | 11.14% |
| Q1 2024 Q2Q % growth | 0.88 16.49% | 0.76 | 0.11 | 14.88% |
| Q4 2023 Q2Q % growth | 0.59 12.02% | 0.60 | -0.01 | -1.98% |
| Q3 2023 Q2Q % growth | 1.02 7.46% | 0.97 | 0.05 | 5.56% |
| Q2 2023 Q2Q % growth | 0.79 12.14% | 0.73 | 0.06 | 7.52% |
| Q1 2023 Q2Q % growth | 0.75 -8.92% | 0.69 | 0.06 | 8.62% |
| Q4 2022 Q2Q % growth | 0.52 -19.38% | 0.46 | 0.06 | 13.62% |
| Q3 2022 Q2Q % growth | 0.95 2.51% | 0.83 | 0.12 | 14.45% |
| Q2 2022 Q2Q % growth | 0.70 -1.49% | 0.60 | 0.10 | 16.49% |
| Q1 2022 Q2Q % growth | 0.83 41.92% | 0.79 | 0.04 | 4.62% |
| Q4 2021 Q2Q % growth | 0.65 9.87% | 0.64 | 0.01 | 1.36% |
| Q3 2021 Q2Q % growth | 0.93 2.81% | 0.76 | 0.17 | 22.51% |
| Q2 2021 Q2Q % growth | 0.71 46.35% | 0.53 | 0.19 | 35.82% |
| Q1 2021 Q2Q % growth | 0.58 -38.77% | 0.56 | 0.02 | 3.70% |
| Q4 2020 Q2Q % growth | 0.59 | 0.61 | -0.02 | -2.81% |
| Q3 2020 Q2Q % growth | 0.90 | 0.80 | 0.10 | 13.09% |
| Q2 2020 Q2Q % growth | 0.49 | 0.53 | -0.04 | -8.23% |
| Q1 2020 Q2Q % growth | 0.95 | 0.80 | 0.15 | 18.15% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2025 Q2Q % growth | 8.547B 6.68% | 8.571B | -24M | -0.28% |
| Q2 2025 Q2Q % growth | 7.986B 1.29% | 7.989B | -3M | -0.04% |
| Q1 2025 Q2Q % growth | 7.516B 2.08% | 7.638B | -122M | -1.60% |
| Q4 2024 Q2Q % growth | 8.117B 0.81% | 7.983B | 134M | 1.68% |
| Q3 2024 Q2Q % growth | 8.012B -1.66% | 8.298B | -286M | -3.45% |
| Q2 2024 Q2Q % growth | 7.884B 9.84% | 7.695B | 189M | 2.46% |
| Q1 2024 Q2Q % growth | 7.363B 5.93% | 7.279B | 84M | 1.15% |
| Q4 2023 Q2Q % growth | 8.052B 9.16% | 7.513B | 539M | 7.17% |
| Q3 2023 Q2Q % growth | 8.147B 4.06% | 7.964B | 183M | 2.30% |
| Q2 2023 Q2Q % growth | 7.178B 3.59% | 7.032B | 146M | 2.08% |
| Q1 2023 Q2Q % growth | 6.951B -3.32% | 6.634B | 317M | 4.78% |
| Q4 2022 Q2Q % growth | 7.376B 4.24% | 7.563B | -187M | -2.47% |
| Q3 2022 Q2Q % growth | 7.829B 18.14% | 7.555B | 274M | 3.63% |
| Q2 2022 Q2Q % growth | 6.929B 18.69% | 6.702B | 227M | 3.39% |
| Q1 2022 Q2Q % growth | 7.19B -3.07% | 9.265B | -2.075B | -22.40% |
| Q4 2021 Q2Q % growth | 7.076B -19.03% | 9.782B | -2.706B | -27.66% |
| Q3 2021 Q2Q % growth | 6.627B -23.35% | 8.986B | -2.359B | -26.25% |
| Q2 2021 Q2Q % growth | 5.838B -23.43% | 7.785B | -1.947B | -25.01% |
| Q1 2021 Q2Q % growth | 7.418B -18.39% | 8.12B | -702M | -8.65% |
| Q4 2020 Q2Q % growth | 8.739B | 9.001B | -262M | -2.91% |
| Q3 2020 Q2Q % growth | 8.646B | 9.034B | -388M | -4.29% |
| Q2 2020 Q2Q % growth | 7.624B | 7.953B | -329M | -4.14% |
| Q1 2020 Q2Q % growth | 9.09B | 8.949B | 141M | 1.58% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | -0.36% | -6.62% | 0.36% | 2.04% |
| Revenue | 0.12% | 1.99% | 0.14% | 1.14% |